Beilstein J. Org. Chem. 2012, 8, 18–24.
exocyclic amino function, followed by cyclization through 13C NMR (100 MHz, DMSO-d6) δ 14.55, 27.89, 32.36, 36.46,
water loss to give 6 (route A). Formation of isomeric product 4, 38.87, 50.08, 98.04, 112.39, 146.03, 149.34, 152.21, 157.52,
which would be formed by route B, was ruled out based on 194.82; EIMS m/z: 229.1 (M+), 214, 173, calcd. for C13H15N3O
spectral and X-ray diffraction data.
229.28; Anal. calcd for C13H15N3O: C, 68.1; H, 6.59; N, 18.33;
found: C, 68.22; H, 6.62; N, 18.35%.
From the data of the X-ray crystal structure it can be concluded
that the bridged head nitrogen has bond angles closer to those of 2-Methyl-8,9-dihydropyrazolo[5,1-b]quinazolin-6(7H)-one
sp3 nitrogen. One may thus conclude that the lone pair on this (6b): Yellow plates, 170 mg (85% yield); mp 154–155 °C; 1H
nitrogen atom does not contribute much to the actual state of the NMR (400 MHz, DMSO-d6) δ 2.21–2.27 (m, 2H, CH2 at C-8),
molecule and that charge-separated ions also do not contribute 2.66 (t, J = 6.8 Hz, 2H, CH2 at C-9), 3.40 (t, J = 6.4 Hz, 2H,
significantly; although, the pyrazolo[5,1-b]quinazolin ring is CH2 at C-7), 6.71 (s,1H, CH at C-3), 8.77 (s, 1H, CH at C-5);
almost planar.
13C NMR (100 MHz, DMSO-d6) δ 14.53, 19.95, 33.37, 36.54,
97.91, 113.3, 146.3, 149.0, 153.9, 157.42, 194.81; EIMS m/z
201.12 (M+), calcd for C11H11N3O 201.22; Anal. calcd for
Conclusion
In summary, we can reveal that the reaction of substituted C11H11N3O: C, 65.66; H, 5.51; N, 20.88; found: C, 65.68; H,
5-aminopyrazoles, cyclic 1,3-diketones and dimethyformamide 5.49; N, 20.67%.
dimethylacetal (DMFDMA, 3) proceeds by initial attack of the
exocyclic amino function. Although an attack by the ring Ethyl 2-amino-6-oxo-6,7,8,9-tetrahydropyrazolo[5,1-
nitrogen has been proposed for the reaction of 5-aminopyra- b]quinazolin-3-carboxylate (6c): Yellow crystals, 243 mg
zoles with acrylonitrile [29], here steric factors hinder such an (89% yield); mp 184–185 °C; 1H NMR (400 MHz, DMSO-d6)
attack and the reaction occurs exclusively, in every case δ 1.31 (t, J = 7.2 Hz, 3H, CH3), 2.10–2.20 (m, 2H, CH2 at C-8),
studied, at the amino function.
2.63 (t, J = 6.8 Hz, 2H, CH2 at C-9), 3.25 (t, J = 6.8 Hz, 2H,
CH2 at C-7), 4.31 (q, J = 6.8 Hz, 2H, CH2), 6.7 (br s, 2H, NH2),
8.82 (s, 1H, CH at C-5); EIMS m/z 274.1 (M+), 228, 174.1,
Experimental
General information. All the reactions were carried out in a calcd for C13H14N4O3 274.28; Anal. calcd for C13H14N4O3: C,
Milestone START Microwave Labstation (temperature control 56.93; H, 5.14; 20.43; found: C, 57.12; H, 5.23; N, 20.45%
by IR sensor). 1H NMR (400 MHz) and 13C NMR (100 MHz)
spectra were measured on a Bruker DPX instrument by using 2,8,8-Trimethyl-3-phenyl-8,9-dihydropyrazolo[5,1-b]quina-
DMSO-d6 as solvent and TMS as internal standard. Chemical zolin-6(7H)-one (6d): Pale yellow crystals, 253 mg (83%
shifts are expressed as δ in ppm. Coupling constants (J) are yield); mp 279–280 °C; 1H NMR (400 MHz, DMSO-d6) δ 1.15
given in Hertz (Hz). The melting points were measured in a (s, 6H, 2 CH3), 2.49 (s, 2H, CH2 at C-9), 2.58 (s, 3H, CH3 at
Gallenkamp melting-point apparatus and are not corrected. C-2), 2.63 (s, 2H, CH2 at C-7), 7.13–7.55 (m, 5H, Ph-H), 8.83
Mass spectra were measured by using VG Autospec Q MS 30 (s, 1H, CH at C-5); 13C NMR (100 MHz, DMSO-d6) δ 14.41,
and MS 9 (AEI) spectrometer with the EI (70 eV) mode.
24.42, 27.90, 36.42, 38.87, 50.15, 112.99, 119.22, 125.88,
126.67, 128.30, 129.20, 132.43, 140.64, 144.52, 159.05,
194.70; EIMS m/z 305.2 (M+), 299, 179.1, calcd for
C19H19N3O 305.37; Anal. calcd for C19H19N3O: C, 74.73; H,
General procedure for the synthesis of pyra-
zoloquinazolinones (6a–g)
A solution of 5-aminopyrazole derivative 1a–f (1 mmol), cyclic 6.27; N, 13.76; found: C, 74.66; H, 6.35, N, 13.82%.
1,3-diketones (2a,b) (1 mmol) and dimethylformamide
dimethylacetal (DMFDMA, 3) (1 mmol) in DMF (10 mL) was 2-Phenyl-8,9-dihydropyrazolo[1,5-a]quinazolin-6(7H)-one
heated under reflux in a Milestone Microwave Labstation at 150 (6e): Pale yellow crystals, 215 mg (82% yield); mp 197–198
°C for 15 min. After concentration and cooling to room °C; 1H NMR (400 MHz, DMSO-d6) δ 2.25 (m, 2H, CH2 at
temperature, the resulting solid product so formed was collected C-8), 2.64 (t, J = 5.6 Hz, 2H, CH2 at C-9), 3.41 (t, J = 5.6 Hz,
by filtration, washed well with EtOH, dried and recrystallized 2H, CH2 at C-7), 7.39 (br s, 1H, CH at C-3), 7.48 (m, 3H,
from EtOH.
Ph-H), 8.08 (d, J = 7.2 Hz, 2H, Ph-H), 8.78 (s, 1H, CH at C-5);
13C NMR (100 MHz, DMSO-d6) δ 19.97, 23.46, 36.63, 79.19,
2,8,8-Trimethyl-8,9-dihydropyrazolo[5,1-b]quinazolin- 95.49, 114.10, 126.44, 129.0, 129.69, 131.85, 146.77, 149.69,
6(7H)-one (6a): Greenish yellow plates, 201 mg (88% yield); 154.39, 157.60, 162.32, 194.84; EIMS m/z 263.1 (M+), 235.1,
mp 134–135 °C; 1H NMR (400 MHz, DMSO-d6) δ 1.12 (s, 6H, 152.1, calcd. for C16H13N3O 263.11; Anal. calcd for
2CH3), 2.48 (s, 3H, CH3), 2.56 (s, 2H, CH2 at C-9), 3.32 (s, 2H, C16H13N3O: C, 72.99; H, 4.98; N, 15.96; found: C, 72.94; H,
CH2 at C-7), 6.70 (s, 1H, CH at C-3), 8.75 (s, 1H, CH at C-5); 5.18; N, 16.32%.
22